SCHEMBL7169449

SCHEMBL7169449

CC(C)(C)Nc1nc(N)ncc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL6 P41182 2/20 0.56
NUDT1 P36639 4/20 0.44
SYK P43405 4/20 0.37
FGFR1 P11362 3/20 0.36
SRC P12931 3/20 0.36
PDGFRB P09619 2/20 0.36
PDGFRA P16234 2/20 0.36
PLK4 O00444 1/20 0.34
AURKA O14965 1/20 0.34
PDPK1 O15530 1/20 0.34
JAK2 O60674 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
NTRK1 P04629 1/20 0.34
INSR P06213 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
CDK1 P06493 1/20 0.34
FES P07332 1/20 0.34
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18855177 0.83 BCL6 (0.50) BCL6NUDT1SYKCDK2LATS1
SCHEMBL2744648 0.79 BCL6 (0.56) BCL6NUDT1SYKFGFR1SRC
SCHEMBL7177583 0.78 ALDH1A1 (0.50) BCL6SYKFGFR1SRCPLK4
SCHEMBL179464 0.76 BCL6 (0.46) BCL6NUDT1SYKFGFR1SRC
SCHEMBL179505 0.76 BCL6 (0.46) BCL6NUDT1SYKFGFR1SRC
SCHEMBL179356 0.76 BCL6 (0.46) BCL6NUDT1SYKFGFR1SRC
SCHEMBL19726934 0.76 BCL6 (0.47) BCL6NUDT1SYKJAK2TYK2
SCHEMBL2745520 0.74 BCL6 (0.51) BCL6NUDT1SYKAURKAJAK2
SCHEMBL20049960 0.74 BCL6 (0.44) BCL6NUDT1SYKFGFR1SRC
SCHEMBL179422 0.73 BCL6 (0.43) BCL6NUDT1SYKJAK2TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0952151-B1 Intermediates for use in preparing novel pyridonecarboxylic acid derivatives or their salts WAKUNAGA PHARMA CO LTD (JP) 2003-05-28 EP disclosed
EP-0911327-B1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR THEIR SALTS AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMA CO LTD (JP) 2001-12-05 EP disclosed
US-6156903-A Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-12-05 US disclosed
US-6133284-A EXCELLENT BACTERICIDAL PROPERTIES AND ORAL ABSORPTION; INFECTIONS FROM GRAMNEGATIVE AND -POSITIVE BACTERIA; INTESTINAL ABSORPTION, METABOLIC STABILITY; SIDE EFFECT REDUCTION; NONPHOTOTOXICITY AND NONCYTOTOXICITY WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-10-17 US disclosed
EP-0992501-A2 Pyridonecarboxylic acid derivatives as antibacterial agents WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
US-5998436-A Pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient WAKUNAGA PHARMACEUTICALS CO., LTD. (JP) 1999-12-07 US disclosed
EP-0952151-A2 Intermediates for use in preparing novel pyridonecarboxylic acid derivatives or their salts WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-10-27 EP disclosed
EP-0911327-A1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR THEIR SALTS AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-04-28 EP disclosed